Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stuart C Gordon

Showing results (101-110 of 214) with videos related to

Pageof 22
Sort By:
Journal of Viral Hepatitis|March 5, 2023
Impact of hepatitis C treatment status on risk of Parkinson's disease and secondary parkinsonism in the era of direct-acting antiviralsRanya Selim, Stuart C Gordon, Yueren Zhou, et al.
Hepatitis Research and Treatment|October 25, 2012
Hepatitis C virus: a critical appraisal of new approaches to therapyDavid R Nelson, Donald M Jensen, Mark S Sulkowski, et al.
Hepatology (Baltimore, Md.)|September 10, 2014
Predictors of poor mental and physical health status among patients with chronic hepatitis C infection: the Chronic Hepatitis Cohort Study (CHeCS)Joseph A Boscarino, Mei Lu, Anne C Moorman, et al.
Hepatology Communications|March 8, 2021
Psychosocial Obstacles to Hepatitis C Treatment Initiation Among Patients in Care: A Hitch in the Cascade of CurePhilip R Spradling, Yuna Zhong, Anne C Moorman, et al.
Population Health Management|August 14, 2023
The Predictive Value of International Classification of Disease Codes for Chronic Hepatitis C Virus Infection Surveillance: The Utility and Limitations of Electronic Health RecordsWinston E Abara, Anne C Moorman, Yuna Zhong, et al.
Gastroenterology|January 24, 2018
Hepatitis B Virus Infection and Hepatitis C Virus Treatment in a Large Cohort of Hepatitis C-Infected Patients in the United StatesAnne C Moorman, Jian Xing, Loralee B Rupp, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 11, 2022
Lower Rates of Emergency Department Visits and Hospitalizations Among Patients With Chronic Hepatitis C With Sustained Virological Response to Interferon-Free Direct-Acting Antiviral Therapy (2014-2018)Stuart C Gordon, Eyasu H Teshale, Philip R Spradling, et al.
The Journal of Infectious Diseases|January 18, 2022
Incidence of Malignancies Among Patients With Chronic Hepatitis B in US Health Care Organizations, 2006-2018Philip R Spradling, Jian Xing, Yuna Zhong, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 4, 2014
Trends in HCV RNA testing among HCV antibody-positive persons in care, 2003-2010Philip R Spradling, Xin Tong, Loralee B Rupp, et al.
Hepatology (Baltimore, Md.)|February 1, 2013
Efficacy of tenofovir disoproxil fumarate at 240 weeks in patients with chronic hepatitis B with high baseline viral loadStuart C Gordon, Zahary Krastev, Andrzej Horban, et al.
Pageof 22

Showing results (101-110 of 214) with videos related to

Sort By:
Pageof 22
Journal of Viral Hepatitis|March 5, 2023
Impact of hepatitis C treatment status on risk of Parkinson's disease and secondary parkinsonism in the era of direct-acting antiviralsRanya Selim, Stuart C Gordon, Yueren Zhou, et al.
Hepatitis Research and Treatment|October 25, 2012
Hepatitis C virus: a critical appraisal of new approaches to therapyDavid R Nelson, Donald M Jensen, Mark S Sulkowski, et al.
Hepatology (Baltimore, Md.)|September 10, 2014
Predictors of poor mental and physical health status among patients with chronic hepatitis C infection: the Chronic Hepatitis Cohort Study (CHeCS)Joseph A Boscarino, Mei Lu, Anne C Moorman, et al.
Hepatology Communications|March 8, 2021
Psychosocial Obstacles to Hepatitis C Treatment Initiation Among Patients in Care: A Hitch in the Cascade of CurePhilip R Spradling, Yuna Zhong, Anne C Moorman, et al.
Population Health Management|August 14, 2023
The Predictive Value of International Classification of Disease Codes for Chronic Hepatitis C Virus Infection Surveillance: The Utility and Limitations of Electronic Health RecordsWinston E Abara, Anne C Moorman, Yuna Zhong, et al.
Gastroenterology|January 24, 2018
Hepatitis B Virus Infection and Hepatitis C Virus Treatment in a Large Cohort of Hepatitis C-Infected Patients in the United StatesAnne C Moorman, Jian Xing, Loralee B Rupp, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 11, 2022
Lower Rates of Emergency Department Visits and Hospitalizations Among Patients With Chronic Hepatitis C With Sustained Virological Response to Interferon-Free Direct-Acting Antiviral Therapy (2014-2018)Stuart C Gordon, Eyasu H Teshale, Philip R Spradling, et al.
The Journal of Infectious Diseases|January 18, 2022
Incidence of Malignancies Among Patients With Chronic Hepatitis B in US Health Care Organizations, 2006-2018Philip R Spradling, Jian Xing, Yuna Zhong, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 4, 2014
Trends in HCV RNA testing among HCV antibody-positive persons in care, 2003-2010Philip R Spradling, Xin Tong, Loralee B Rupp, et al.
Hepatology (Baltimore, Md.)|February 1, 2013
Efficacy of tenofovir disoproxil fumarate at 240 weeks in patients with chronic hepatitis B with high baseline viral loadStuart C Gordon, Zahary Krastev, Andrzej Horban, et al.
Pageof 22